Literature DB >> 9501080

Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A.

A van der Spoel1, E Bonten, A d'Azzo.   

Abstract

Human lysosomal N-acetyl-alpha-neuraminidase is deficient in two lysosomal storage disorders, sialidosis, caused by structural mutations in the neuraminidase gene, and galactosialidosis, in which a primary defect of protective protein/cathepsin A (PPCA) leads to a combined deficiency of neuraminidase and beta-D-galactosidase. These three glycoproteins can be isolated in a high molecular weight multi-enzyme complex, and the enzymatic activity of neuraminidase is contingent on its interaction with PPCA. To explain the unusual need of neuraminidase for an auxiliary protein, we examined, in transfected COS-1 cells, the effect of PPCA expression on post-translational modification, turnover and intracellular localization of neuraminidase. In pulse-chase studies, we show that the enzyme is synthesized as a 46 kDa glycoprotein, which is poorly phosphorylated, does not undergo major proteolytic processing and is secreted. Importantly, its half-life is not altered by the presence of PPCA. However, neuraminidase associates with the PPCA precursor shortly after synthesis, since the latter protein co-precipitates with neuraminidase using anti-neuraminidase antibodies. We further demonstrate by subcellular fractionation of transfected cells that neuraminidase segregates to mature lysosomes only when accompanied by wild-type PPCA, but not by transport-impaired PPCA mutants. These data suggest a novel role for PPCA in the activation of lysosomal neuraminidase, that of an intracellular transport protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9501080      PMCID: PMC1170506          DOI: 10.1093/emboj/17.6.1588

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

Review 1.  Mannose 6-phosphate receptors in sorting and transport of lysosomal enzymes.

Authors:  A Hille-Rehfeld
Journal:  Biochim Biophys Acta       Date:  1995-07-17

Review 2.  Intracellular trafficking of lysosomal membrane proteins.

Authors:  W Hunziker; H J Geuze
Journal:  Bioessays       Date:  1996-05       Impact factor: 4.345

Review 3.  How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway.

Authors:  P R Wolf; H L Ploegh
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

4.  Cathepsin A deficiency in galactosialidosis: studies of patients and carriers in 16 families.

Authors:  W J Kleijer; G C Geilen; H C Janse; O P van Diggelen; X Y Zhou; N J Galjart; H Galjaard; A d'Azzo
Journal:  Pediatr Res       Date:  1996-06       Impact factor: 3.756

5.  Association of N-acetylgalactosamine-6-sulfate sulfatase with the multienzyme lysosomal complex of beta-galactosidase, cathepsin A, and neuraminidase. Possible implication for intralysosomal catabolism of keratan sulfate.

Authors:  A V Pshezhetsky; M Potier
Journal:  J Biol Chem       Date:  1996-11-08       Impact factor: 5.157

6.  Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells.

Authors:  X Y Zhou; H Morreau; R Rottier; D Davis; E Bonten; N Gillemans; D Wenger; F G Grosveld; P Doherty; K Suzuki; G C Grosveld; A d'Azzo
Journal:  Genes Dev       Date:  1995-11-01       Impact factor: 11.361

7.  Lysosomal protective protein/cathepsin A. Role of the "linker" domain in catalytic activation.

Authors:  E J Bonten; N J Galjart; R Willemsen; M Usmany; J M Vlak; A d'Azzo
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

8.  Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements.

Authors:  M Fornerod; J Boer; S van Baal; M Jaeglé; M von Lindern; K G Murti; D Davis; J Bonten; A Buijs; G Grosveld
Journal:  Oncogene       Date:  1995-05-04       Impact factor: 9.867

9.  Intracellular sorting of aspartylglucosaminidase: the role of N-linked oligosaccharides and evidence of Man-6-P-independent lysosomal targeting.

Authors:  R Tikkanen; N Enomaa; A Riikonen; E Ikonen; L Peltonen
Journal:  DNA Cell Biol       Date:  1995-04       Impact factor: 3.311

Review 10.  Sialic acids structure-analysis-metabolism-occurrence-recognition.

Authors:  G Reuter; H J Gabius
Journal:  Biol Chem Hoppe Seyler       Date:  1996-06
View more
  33 in total

Review 1.  Multifarious roles of sialic acids in immunity.

Authors:  Ajit Varki; Pascal Gagneux
Journal:  Ann N Y Acad Sci       Date:  2012-04       Impact factor: 5.691

Review 2.  The blood-epididymis barrier and inflammation.

Authors:  Mary Gregory; Daniel G Cyr
Journal:  Spermatogenesis       Date:  2014-12-31

3.  Preclinical dose-finding study with a liver-tropic, recombinant AAV-2/8 vector in the mouse model of galactosialidosis.

Authors:  Huimin Hu; Elida Gomero; Erik Bonten; John T Gray; Jim Allay; Yanan Wu; Jianrong Wu; Christopher Calabrese; Arthur Nienhuis; Alessandra d'Azzo
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

4.  Neuraminidase-1 mediates skeletal muscle regeneration.

Authors:  Juliana de Carvalho Neves; Vanessa Rodrigues Rizzato; Alan Fappi; Mariana Miranda Garcia; Gerson Chadi; Diantha van de Vlekkert; Alessandra d'Azzo; Edmar Zanoteli
Journal:  Biochim Biophys Acta       Date:  2015-05-19

5.  Muscle degeneration in neuraminidase 1-deficient mice results from infiltration of the muscle fibers by expanded connective tissue.

Authors:  Edmar Zanoteli; Diantha van de Vlekkert; Erik J Bonten; Huimin Hu; Linda Mann; Elida M Gomero; A John Harris; Giulio Ghersi; Alessandra d'Azzo
Journal:  Biochim Biophys Acta       Date:  2010-04-11

Review 6.  Lysosomal multienzyme complex: pros and cons of working together.

Authors:  Erik J Bonten; Ida Annunziata; Alessandra d'Azzo
Journal:  Cell Mol Life Sci       Date:  2013-12-15       Impact factor: 9.261

7.  Fluorous iminoalditols act as effective pharmacological chaperones against gene products from GLB₁ alleles causing GM1-gangliosidosis and Morquio B disease.

Authors:  Katrin M Fantur; Tanja M Wrodnigg; Arnold E Stütz; Bettina M Pabst; Eduard Paschke
Journal:  J Inherit Metab Dis       Date:  2011-10-28       Impact factor: 4.982

8.  NEU1 sialidase regulates the sialylation state of CD31 and disrupts CD31-driven capillary-like tube formation in human lung microvascular endothelia.

Authors:  Chunsik Lee; Anguo Liu; Alba Miranda-Ribera; Sang Won Hyun; Erik P Lillehoj; Alan S Cross; Antonino Passaniti; P Richard Grimm; Bo-Young Kim; Paul A Welling; Joseph A Madri; Horace M DeLisser; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

9.  Protective protein/cathepsin A rescues N-glycosylation defects in neuraminidase-1.

Authors:  Dongning Wang; Slava Zaitsev; Garry Taylor; Alessandra d'Azzo; Erik Bonten
Journal:  Biochim Biophys Acta       Date:  2009-04

10.  Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis.

Authors:  Erik J Bonten; Gouri Yogalingam; Huimin Hu; Elida Gomero; Diantha van de Vlekkert; Alessandra d'Azzo
Journal:  Biochim Biophys Acta       Date:  2013-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.